Skip to main content
. 2021 Apr 19;11:8527. doi: 10.1038/s41598-021-87989-z

Table 2.

Donor chimerism during neuro-immunologic disease.

Patient Day after alloHSCT % chimerism
PBMCs CD4+ T cells CD8+ T cells CD19+ B cells
#1 d1519 100 100 100 95
#2 d241 100 100 100 100
#3 d440 100 100 100 100

LGI-1-, GAD-, MOG- and SSA(Ro)-IgG were neither detectable in the respective patient’s serum before alloHSCT nor in the respective donor’s serum.